Literature DB >> 14609568

CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis.

Mehrnaz Gharaee-Kermani1, Robert E McCullumsmith, Israel F Charo, Steven L Kunkel, Sem H Phan.   

Abstract

MCP-1, which signals via the CC chemokine receptor 2 (CCR2), is induced in lung fibrosis that is accompanied by mononuclear cell recruitment and activation of lung fibroblasts. To evaluate the role of CCR2 in lung fibrosis, CCR2 knockout (ko) mice were used in a model of bleomycin-induced lung fibrosis. Wild type (wt) and ko mice were injected endotracheally with bleomycin to induce lung injury and fibrosis, and then analyzed for degree of lung fibrosis and cytokine expression. The results showed significantly reduced fibrosis in ko mice as evidenced by decreased lung type I collagen gene expression and hydroxyproline content relative to those in wt mice. Lung TNF-alpha and TGF-beta1 expression was significantly lower in ko vs. wt mice, while MCP-1 expression was unaffected. Interestingly, lung alpha-smooth muscle actin (alpha-SMA) expression, a marker for myofibroblast differentiation, was also decreased in ko mice, which was confirmed by analysis of isolated lung fibroblasts. Fibroblasts from ko mice exhibited decreased responsiveness to TGF-beta1 induced alpha-SMA expression, which was associated with reduced expression of TGF-beta receptor II (TbetaRII) and Smad3. These findings suggest that CCR2 signaling plays a key role in bleomycin-induced pulmonary fibrosis by regulating fibrogenic cytokine expression and fibroblast responsiveness to TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609568     DOI: 10.1016/j.cyto.2003.08.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  46 in total

1.  A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury.

Authors:  Jiurong Liang; Yoosun Jung; Robert M Tighe; Ting Xie; Ningshan Liu; Maura Leonard; Michael Dee Gunn; Dianhua Jiang; Paul W Noble
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

2.  Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Authors:  Daniela Damjanovic; Maziar Divangahi; Kapilan Kugathasan; Cherrie-Lee Small; Anna Zganiacz; Earl G Brown; Cory M Hogaboam; Jack Gauldie; Zhou Xing
Journal:  Am J Pathol       Date:  2011-10-14       Impact factor: 4.307

3.  Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Authors:  Rachel Nadif; Margaret Mintz; Selma Rivas-Fuentes; Anne Jedlicka; Elise Lavergne; Mathieu Rodero; Francine Kauffmann; Christophe Combadière; Steven R Kleeberger
Journal:  Cytokine       Date:  2006-02-07       Impact factor: 3.861

4.  Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage.

Authors:  Shigeki Saito; Takayuki Nakayama; Naozumi Hashimoto; Yasuhiko Miyata; Kensuke Egashira; Norihiko Nakao; Satoshi Nishiwaki; Minoru Hasegawa; Yoshinori Hasegawa; Tomoki Naoe
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

Review 5.  Interleukin-17: Friend or foe in organ fibrosis.

Authors:  Kritika Ramani; Partha S Biswas
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

Review 6.  Targeted therapies for systemic sclerosis.

Authors:  Christopher P Denton; Voon H Ong
Journal:  Nat Rev Rheumatol       Date:  2013-04-09       Impact factor: 20.543

7.  Following the path of CCL2 from prostaglandins to periostin in lung fibrosis.

Authors:  Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

8.  Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.

Authors:  Joseph A Sennello; Alexander V Misharin; Annette S Flozak; Sergejs Berdnikovs; Paul Cheresh; John Varga; David W Kamp; G R Scott Budinger; Cara J Gottardi; Anna P Lam
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

9.  CCR2 promotes hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele de Minicis; Sayaka Inokuchi; Kojiro Taura; Katsumi Miyai; Nico van Rooijen; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

10.  Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

Authors:  Kathy Boon; Nathaniel W Bailey; Jun Yang; Mark P Steel; Steve Groshong; Dolly Kervitsky; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  PLoS One       Date:  2009-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.